Elevated serum IGF-1 levels in PD patients have been negatively correlated with nonmotor symptoms, such as anxiety, depression, and cognitive dysfunction, and combining IGF-1 with EGF enhances the diagnostic value for PD (Shi et al., 2023). This evidence concerns the gene EGF and major depressive disorder.